In yesterday’s edition of the largest newspaper in Norway, VG, the editorial team highlighted the importance of taking atrial fibrillation seriously.

It is a privilege for us at ECG247 to be the technology provider for the world’s largest atrial fibrillation study, NORSCREEN, with over 25,000 participants using our sensor and software. It is highly motivating to be part of research that may help prevent unnecessary strokes and heart failure. Every day, we receive positive feedback from participants who emphasize the importance of studying atrial fibrillation and its connection to stroke.

A big thank you to Oslo University Hospital, with project leader professor Sigrun Halvorsen at the helm, and to the other participating hospitals that make this exciting project possible.